rs75400929

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001127198.5(TMC6):​c.1505C>T​(p.Pro502Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00827 in 1,613,348 control chromosomes in the GnomAD database, including 120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P502P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0072 ( 15 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 105 hom. )

Consequence

TMC6
NM_001127198.5 missense

Scores

3
10
5

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.46

Publications

8 publications found
Variant links:
Genes affected
TMC6 (HGNC:18021): (transmembrane channel like 6) Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 10 transmembrane domains and 2 leucine zipper motifs. [provided by RefSeq, Jul 2008]
TMC6 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis, susceptibility to, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065681934).
BP6
Variant 17-78121043-G-A is Benign according to our data. Variant chr17-78121043-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 456008.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00724 (1102/152300) while in subpopulation NFE AF = 0.00906 (616/68012). AF 95% confidence interval is 0.00847. There are 15 homozygotes in GnomAd4. There are 600 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMC6NM_001127198.5 linkc.1505C>T p.Pro502Leu missense_variant Exon 12 of 20 ENST00000590602.6 NP_001120670.1 Q7Z403-1A0A024R8V2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMC6ENST00000590602.6 linkc.1505C>T p.Pro502Leu missense_variant Exon 12 of 20 2 NM_001127198.5 ENSP00000465261.1 Q7Z403-1

Frequencies

GnomAD3 genomes
AF:
0.00724
AC:
1102
AN:
152182
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0371
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00906
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00849
AC:
2126
AN:
250436
AF XY:
0.00807
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00140
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0382
Gnomad NFE exome
AF:
0.00976
Gnomad OTH exome
AF:
0.0105
GnomAD4 exome
AF:
0.00838
AC:
12247
AN:
1461048
Hom.:
105
Cov.:
32
AF XY:
0.00803
AC XY:
5838
AN XY:
726844
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33478
American (AMR)
AF:
0.00141
AC:
63
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00217
AC:
187
AN:
86258
European-Finnish (FIN)
AF:
0.0390
AC:
2050
AN:
52610
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00853
AC:
9489
AN:
1111996
Other (OTH)
AF:
0.00672
AC:
406
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
853
1706
2559
3412
4265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00724
AC:
1102
AN:
152300
Hom.:
15
Cov.:
32
AF XY:
0.00806
AC XY:
600
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00125
AC:
52
AN:
41560
American (AMR)
AF:
0.000719
AC:
11
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4824
European-Finnish (FIN)
AF:
0.0371
AC:
394
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00906
AC:
616
AN:
68012
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
56
113
169
226
282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00774
Hom.:
36
Bravo
AF:
0.00447
TwinsUK
AF:
0.0102
AC:
38
ALSPAC
AF:
0.0104
AC:
40
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.00858
AC:
1042
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00540
EpiControl
AF:
0.00640

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TMC6: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epidermodysplasia verruciformis Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.087
T
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T;T;T;.;.
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
.;.;D;D;D
MetaRNN
Benign
0.0066
T;T;T;T;T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Uncertain
2.9
M;M;M;.;.
PhyloP100
4.5
PrimateAI
Uncertain
0.51
T
PROVEAN
Pathogenic
-9.6
.;D;D;.;.
REVEL
Uncertain
0.63
Sift
Pathogenic
0.0
.;D;D;.;.
Sift4G
Uncertain
0.0020
D;D;D;D;D
Polyphen
1.0
D;D;D;D;D
Vest4
0.39
MVP
0.69
MPC
0.68
ClinPred
0.053
T
GERP RS
3.9
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.7
Varity_R
0.79
gMVP
0.62
Mutation Taster
=73/27
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75400929; hg19: chr17-76117124; COSMIC: COSV59809884; COSMIC: COSV59809884; API